HuGE Literature Finder
Records
1
-
4
Polymorphisms in matrix metalloproteinases 2, 3, and 8 increase recurrence and mortality risk by regulating enzyme activity in gastric adenocarcinoma. Oncotarget 2017 Dec 8 (62): 105971-105983. Lin Youdong, Liu Jinsheng, Jin Long, Jiang Y |
Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma. International journal of cancer. Journal international du cancer 2012 Dec 131 (11): 2478-86. Cheung Winson Y, Zhai Rihong, Bradbury Penny, Hopkins Jessica, Kulke Matthew H, Heist Rebecca S, Asomaning Kofi, Ma Clement, Xu Wei, Wang Zhaoxi, Hooshmand Suzanne, Su Li, Christiani David C, Liu Geoffr |
Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis. Carcinogenesis 2009 Mar . Bradbury PA, Zhai R, Hopkins J, Kulke MH, Heist RS, Singh S, Zhou W, Ma C, Xu W, Asomaning K, Ter-Minassian M, Wang Z, Su L, Christiani DC, Liu G |
No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China. World journal of gastroenterology : WJG 2005 Apr 11 (16): 2385-9. Jin Xia, Kuang Gang, Wei Li-Zhen, Li Yan, Wang Rui, Guo Wei, Wang Na, Fang Shu-Mei, Wen Deng-Gui, Chen Zhi-Feng, Zhang Jian-H |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 26, 2022
- Content source: